Yahoo Web Search

Search results

  1. Apr 24, 2019 · A prominent pediatrician and medical researcher in the Philippines has been indicted over the failed—and many say prematureintroduction of Dengvaxia, a vaccine against dengue that was yanked from the Philippine market in 2017 because of safety issues.

  2. Jun 23, 2021 · CHAPEL HILL, NC – Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.

  3. Apr 15, 2023 · Dengue surveillance in the phase III trial extended for 4.5 years. The primary study endpoint for the phase III trial was efficacy against any dengue, of any severity, caused by any DENV type...

  4. Jan 19, 2022 · Key Facts. One type of dengue vaccine is available for use in areas with risk of dengue in the United States: Dengvaxia® dengue vaccine. Who Should Get a Dengue Vaccine? CDC recommends dengue vaccination for children 9 through 16 years old, but only when they have been previously infected with dengue and living in areas where dengue is common.

  5. Jan 31, 2024 · In 2019, the four serotypes of the mosquito-borne dengue virus (DENV) caused an estimated 56 million cases of disease and 5000 to 40,000 deaths in a global swath of tropical and near-tropical...

  6. Apr 1, 2019 · How the World’s First Dengue Vaccination Drive Ended in Disaster. Is a runaway immune reaction making a dengue vaccine dangerous? By Seema Yasmin & Madhusree Mukerjee. Aedes aegypti mosquito...

  7. We believe that the unanticipated results of the dengue vaccine efficacy trial in Thailand call for new methods of assessing dengue immunity. Myeloid cells are major targets of dengue infection in humans.

  1. People also search for